All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0123-ZP135 | Anti-DLL3 (DL306) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | DL306 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP136 | Anti-DLL3 (DL301) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | DL301 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-LX161 | Anti-DLL3 VHH(X3XH161) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH161 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX162 | Anti-DLL3 VHH(X3XH162) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH162 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX524 | Anti-DLL3 VHH(X3XH155) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH155 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX525 | Anti-DLL3 VHH(X3XH156) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH156 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX526 | Anti-DLL3 VHH(X3XH157) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH157 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX527 | Anti-DLL3 VHH(X3XH158) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH158 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX528 | Anti-DLL3 VHH(X3XH159) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH159 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX529 | Anti-DLL3 VHH(X3XH160) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH160 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX530 | Anti-DLL3 VHH(X3XH161) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH161 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX531 | Anti-DLL3 VHH(X3XH162) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH162 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX893 | Anti-DLL3 VHH(X3XH155) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH155 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX894 | Anti-DLL3 VHH(X3XH156) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH156 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX895 | Anti-DLL3 VHH(X3XH157) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH157 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX896 | Anti-DLL3 VHH(X3XH158) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH158 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX897 | Anti-DLL3 VHH(X3XH159) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH159 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX898 | Anti-DLL3 VHH(X3XH160) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH160 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX899 | Anti-DLL3 VHH(X3XH161) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH161 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX900 | Anti-DLL3 VHH(X3XH162) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH162 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX36 | Anti-hDLL3 (MAB) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | MAB | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION